Spleen and MLNs were removed from C57.BL/6, Adamts5-/-Vcan+/+, and Adamts5-/-Vcan+/hdf mice and processed at day 10 p.i., and single cell suspensions were analysed for influenza-specific immunity. (A) Total CD8+ T cell numbers were determined at day 10 p.i. in the spleen. (B) Influenza-specific DbNP366-374+ CD8+ and DbPA224-233+ CD8+ tetramer positive T cells in the spleen were enumerated at day 10 p.i. CD8+ T cell functionality was measured using ICS. (C) Influenza specific DbNP366-374+IFNγ+CD8+ and DbPA224-233+IFNγ+CD8+ T cell responses were characterised in the spleen at days 10 p.i. (D) Total CD8+ T cell numbers were assessed at day 10 p.i. in the pooled MLN. (E) Influenza-specific DbNP366-374+ CD8+ and DbPA224-233+ CD8+ tetramer positive T cells in the pooled MLN were enumerated at day 10 p.i. CD8+ T cell functionality was measured using ICS. (F) Influenza-specific DbNP366-374+IFNγ+CD8+ and DbPA224-233+IFNγ+CD8+ T cell responses were characterised in the pooled MLN at day 10 p.i. The results are expressed as means ± SD (spleen data) or as pooled means (MLN data), and statistical significance (relative to C57.BL/6 mice) was determined by one-way ANOVA (*p ≤ 0.05, ***p ≤ 0.005 relative to C57.BL/6, n = 5 representing three individual experiments). WT denotes C57.BL/6 mice and ts5-/- denotes Adamts5-/-. (G) Our model for ADAMTS5 enzyme activity and T cell migration proposes that versican can inhibit T cell effector function by acting as a physical block. Cleavage of versican by ADAMTS5 removes the ECM blockade, allowing migration (top panel). Moreover, versican accumulation in the absence of ADAMTS enzyme activity results in T cell clustering (bottom panel). Underlying data are provided in S1 Data.